-
EP2780373
European procedure
Extract from the Register of European Patents
EP About this file: EP2780373
| EP2780373 - ANTI IL-36R ANTIBODIES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.07.2020 Database last updated on 06.12.2024 | |
| Former | The patent has been granted Status updated on 19.07.2019 | ||
| Former | Grant of patent is intended Status updated on 17.07.2019 | ||
| Former | Examination is in progress Status updated on 09.07.2019 | ||
| Former | Grant of patent is intended Status updated on 03.03.2019 | ||
| Former | Examination is in progress Status updated on 03.02.2017 | Most recent event Tooltip | 03.07.2020 | No opposition filed within time limit | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2019/34] |
| Former [2014/39] | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Inventor(s) | 01 /
BROWN, Su-Ellen Boehringer Ingelheim USA Corp. c/o VP IP Legal 900 Ridgebury Road, P.O. Box 368 Ridgefield, Connecticut 06877-0368 / US | 02 /
CANADA, Keith Boehringer Ingelheim USA Corp. c/o VP IP Legal 900 Ridgebury Road, P.O. Box 368 Ridgefield, Connecticut 06877-0368 / US | 03 /
CHLEWICKI, Lukasz Boehringer Ingelheim USA Corp. c/o VP IP Legal 900 Ridgebury Road, P.O. Box 368 Ridgefield, Connecticut 06877-0368 / US | 04 /
HOWELL, Michael Boehringer Ingelheim USA Corp. c/o VP IP Legal 900 Ridgebury Road, P.O. Box 368 Ridgefield, Connecticut 06877-0368 / US | 05 /
MENNERICH, Detlev Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | 06 /
WOSKA JR., Joseph Robert Boehringer Ingelheim USA Corp. c/o VP IP Legal 900 Ridgebury Road, P.O. Box 368 Ridgefield, Connecticut 06877-0368 / US | [2014/39] | Representative(s) | Oetke, Cornelia Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB Zweibrückenstraße 5-7 80331 München / DE | [2019/34] |
| Former [2014/39] | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Application number, filing date | 12788410.4 | 14.11.2012 | [2019/34] | WO2012US64933 | Priority number, date | US201161560554P | 16.11.2011 Original published format: US 201161560554 P | US201261644111P | 08.05.2012 Original published format: US 201261644111 P | US201261713713P | 15.10.2012 Original published format: US 201261713713 P | [2014/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013074569 | Date: | 23.05.2013 | Language: | EN | [2013/21] | Type: | A1 Application with search report | No.: | EP2780373 | Date: | 24.09.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.05.2013 takes the place of the publication of the European patent application. | [2014/39] | Type: | B1 Patent specification | No.: | EP2780373 | Date: | 21.08.2019 | Language: | EN | [2019/34] | Search report(s) | International search report - published on: | EP | 23.05.2013 | Classification | IPC: | C07K16/28, A61P17/06 | [2014/39] | CPC: |
C07K16/2866 (EP,CN,EA,KR,US);
A61P17/06 (EP,EA,KR,US);
C07K16/244 (EA,US);
G01N33/564 (EP,EA,KR,US);
G01N33/6869 (EA,US);
A61K2039/505 (EP,CN,EA,KR,US);
C07K2317/24 (EP,CN,EA,KR,US);
C07K2317/33 (EA,US);
C07K2317/565 (EA,US);
C07K2317/76 (EP,CN,EA,KR,US);
C07K2317/92 (EP,CN,EA,KR,US);
G01N2333/7155 (EA,KR,US);
G01N2800/205 (EP,EA,KR,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/39] | Extension states | BA | 16.06.2014 | ME | 16.06.2014 | Title | German: | ANTI IL-36R-ANTIKÖRPER | [2014/39] | English: | ANTI IL-36R ANTIBODIES | [2014/39] | French: | ANTICORPS ANTI-IL-36R | [2014/39] | Entry into regional phase | 16.06.2014 | National basic fee paid | 16.06.2014 | Designation fee(s) paid | 16.06.2014 | Examination fee paid | Examination procedure | 16.06.2014 | Examination requested [2014/39] | 02.03.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 08.05.2015 | Amendment by applicant (claims and/or description) | 04.03.2016 | Despatch of a communication from the examining division (Time limit: M04) | 20.06.2016 | Reply to a communication from the examining division | 25.01.2017 | Despatch of a communication from the examining division (Time limit: M06) | 04.08.2017 | Reply to a communication from the examining division | 11.02.2019 | Cancellation of oral proceeding that was planned for 15.02.2019 | 15.02.2019 | Date of oral proceedings (cancelled) | 04.03.2019 | Communication of intention to grant the patent | 04.07.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.07.2019 | Fee for grant paid | 04.07.2019 | Fee for publishing/printing paid | 17.07.2019 | Information about intention to grant a patent | 17.07.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19169065.0 / EP3536710 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.03.2016 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/32] | Request for further processing for: | 08.05.2015 | Request for further processing filed | 08.05.2015 | Full payment received (date of receipt of payment) Request granted | 21.05.2015 | Decision despatched | Fees paid | Renewal fee | 01.12.2014 | Renewal fee patent year 03 | 30.11.2015 | Renewal fee patent year 04 | 30.11.2016 | Renewal fee patent year 05 | 30.11.2017 | Renewal fee patent year 06 | 30.11.2018 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 21.08.2019 | [2020/28] | Cited in | International search | [Y]WO2008033333 (AMGEN INC [US], et al); | [Y]WO2010025369 (WYETH CORP [US], et al); | by applicant | US4179337 | WO8101145 | US4275149 | US4301144 | US4318980 | EP0073657 | US4419446 | US4485045 | US4496689 | US4544545 | US4560655 | EP0183070 | US4601978 | WO8700195 | US4640835 | US4657866 | US4670417 | EP0244234 | US4737456 | US4741900 | US4767704 | WO8807378 | US4791192 | US4816567 | DD266710 | WO9003430 | US4927762 | US4965199 | WO9013646 | US4975278 | EP0402226 | US5013556 | US5122469 | WO9404188 | WO9411026 | WO9632478 | US5888809 | US6407213 |